ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

TMBSY TME Pharma BSA Y

0.0004
0.00 (0.00%)
May 30 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End December 30 2023 20162017201820192020202120222023
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Total Revenue 503k261k378k279k147k82k34k17k
Operating Income -8.61M-4.73M-4.32M-3.94M-5.75M-13.45M-12M-5.62M
Pre Tax Income -10.73M-5.39M-10.74M-860k-10.41M-14.45M-15.13M-6.73M
Net Income -10.76M-5.39M-10.73M-861k-10.41M-14.45M-15.13M-6.74M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -5.245-2.348-1.06-0.066-0.221-0.194-8.702-0.389
EBIT -8.61M-4.73M-4.32M-3.94M-5.75M-13.45M-12M-5.62M
EBITDA -8.27M-4.7M-4.3M-3.9M-5.69M-13.39M-11.9M-5.48M

Your Recent History

Delayed Upgrade Clock